| Date |
Speaker |
Topic |
| 9/14/2010 |
Ken Saag, MD, MSc (University of Alabama at Birmingham) |
Use of glucocorticoids in treatment: risks, benefits and choice of
agents to prevent GIO |
| 9/21/2010 |
E. Dale Abel, MD (University of Utah) |
Novel insights into the cardiovascular consequences of insulin
resistance |
| 10/5/2010 |
Mark DeBoer, MD (Pediatric Endocrinology) |
Endocrine sequelae of childhood cancer treatment |
| 10/12/2010 |
Eugene Barrett, MD, PhD |
Insulin resistance: how it is measured and what are the
limitations |
| 10/26/2010 |
Susanna Keller, MD |
Rab GAPs and regulation of glucose homeostasis |
| 11/2/2010 |
Michael Thorner, MBBS, DSc,
FRCP, MACP |
Is insulin resistance friend or foe? |
| 11/9/2010 |
Sue Brown, MD |
Denosumab: updates in osteoporosis treatment |
| 11/16/2010 |
Ayotunde Dokun, MD, PhD |
Nature and Nurture in the pathogenesis of peripheral arterial
disease |
| 11/30/2010 |
Robin Felder, PhD (Clinical Chemistry and Toxicology) |
To salt or not to salt: the molecular basis of salt
sensitivity |
| 12/14/2010 |
Michael Sellix, PhD (Biology) |
Gaining ground while gaining weight: understanding the role of the
circadian clock in metabolic disease |
| 12/21/2010 |
Shetal Padia, MD |
Obesity-associated hypertension |
| 1/11/2011 |
Helmy Siragy, MD |
Is there an ideal treatment for hyponatremia? |
| 1/25/2011 |
Erica Ungewitter, PhD (NIH, NIEHS) |
Δ-40p53 controls IGF signaling and stem cell potency |
| 2/1/2011 |
Mary Lee Vance, MD |
Prolactinoma: diagnosis and treatment |
| 2/22/2011 |
Adrian Halme, PhD (Cell Biology) |
|
| 3/1/2011 |
Joyce Green-Pastors, RD, MS, CDE, & Terry Saunders,
PhD
|
The use of standardized patient cases to teach diabetes clinical
care skills to general medicine residents on Endocrine rotation |
| 3/8/2011 |
William F. Young, Jr, MD, MSc, ELS (Mayo Clinic) (Crispell
Lecture)
|
Pheochromocytoma: Tricks and Traps |
| 3/15/2011 |
Farah Morgan, MD / Jennifer Kirby, MD, PhD |
Metabolic consequences of HIV and its treatment (Morgan) /
Osteoporosis in men: risk factors, screening, and treatment
(Kirby) |
| 3/22/2011 |
Eugene Barrett, MD, PhD |
Cardiovascular disease and diabetes - when and how to
intervene? |
| 4/5/2011 |
Matthew Sauder, MD |
From Greenland to New Zealand: exploring alternative therapies in
endocrinology |
| 4/12/2011 |
Ken Burman, MD (Washington Hospital Center) |
Differentiated thyroid cancer: recent advances |
| 4/19/2011 |
Kenneth Brayman, MD, PhD (Surgery)
|
Update on beta cell replacement therapy |
| 4/26/2011 |
Darlene Berryman, PhD, RD (Ohio University)
|
Growth hormone and adipose tissue: it's all in the depot |
| 5/3/2011 |
Christopher McCartney, MD |
Cross-sex hormone administration to persons with gender identity
disorder: philosophical and practical dilemmas |
| 5/10/2011 |
Jennifer Beller, MD / William Smith, MD
|
Premature ovarian failure: evaluation and treatment considerations
(Beller) / Male infertility: and endocrinological perspective
(Smith) |
| 5/17/2011 |
Gregory Hong, MD, PhD / Jessicah Collins, MD |
Sepsis and adrenal insufficiency: is it worth stressing over?
(Hong) / Polycystic ovary syndrome and disordered sleep (Collins) |
| 5/24/2011 |
Charles Upchurch, MD / Cristina Gherghe, MD, PhD |
Microalbuminuria and cardiovascular outcomes (Upchurch) / Please
don't stress! (Gherghe) |
| 5/31/2011 |
Rodney Snow, MD |
|
